Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.
Nishiguchi, G.A., Atallah, G., Bellamacina, C., Burger, M.T., Ding, Y., Feucht, P.H., Garcia, P.D., Han, W., Klivansky, L., Lindvall, M.(2011) Bioorg Med Chem Lett 21: 6366-6369
- PubMed: 21945284 
- DOI: https://doi.org/10.1016/j.bmcl.2011.08.105
- Primary Citation of Related Structures:  
3T9I - PubMed Abstract: 
A series of novel 3,5-disubstituted indole derivatives as potent and selective inhibitors of all three members of the Pim kinase family is described. High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold. Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compounds against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC(50)≤2nM and Pim-2: IC(50)≤100nM).
Organizational Affiliation: 
Global Discovery Chemistry/Oncology and Exploratory Chemistry, Novartis Institutes of BioMedical Research, Emeryville, CA 94608, USA. gisele.nishiguchi@novartis.com